OP-101

· Orpheris, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OP-101, covering 2021-06-14 to 2021-06-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers [Phase 1]

See pricing